Sign in
4/A

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001628280-25-003185

Director acquired 2,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Galante Joseph C Director 2024-03-25 Grant or award +2,500 $1.71 $4,275 60,856 D
Loading xslF345X05/wk-form4a_1738273177.xml…